60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
60 Degrees Pharmaceuticals's total assets was $4.28M at Jun 30, 2026. For fiscal 2025 it was $5.37M, down 6.8% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.37M | -6.8% |
| FY2024 | Dec 31, 2024 | $5.76M | -26.0% |
| FY2023 | Dec 31, 2023 | $7.78M | +500.0% |
| FY2022 | Dec 31, 2022 | $1.30M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.28M | +2.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.76M | +13.1% |
| Q4 FY2025 | Dec 31, 2025 | $5.37M | -6.8% |
| Q3 FY2025 | Sep 30, 2025 | $6.69M | -9.9% |
| Q2 FY2025 | Jun 30, 2025 | $4.18M | -3.4% |
| Q1 FY2025 | Mar 31, 2025 | $5.98M | -28.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.76M | -26.0% |
| Q3 FY2024 | Sep 30, 2024 | $7.42M | -18.9% |
| Q2 FY2024 | Jun 30, 2024 | $4.33M | -41.2% |
| Q1 FY2024 | Mar 31, 2024 | $8.38M | +545.9% |
| Q4 FY2023 | Dec 31, 2023 | $7.78M | – |
| Q3 FY2023 | Sep 30, 2023 | $9.15M | – |
| Q2 FY2023 | Jun 30, 2023 | $7.36M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.30M | – |